Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Healthcare Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • Common Ground
    • Diagnosis: Debt
    • The Body Shops
    • Priced Out
    • Guns, Race, and Profit
    • Broken Rehab
    • Dead Zone
    • Denied
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Healthcare Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health
    All Topics

  • Medicare Advantage Billing Probe
  • School Vaccine Mandates
  • Weight Loss Drugs Coverage
  • Opioid Settlement Money
  • Abortion Pill Access

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Monday, Oct 17 2016

Full Issue

With New Drug To Help Addicts, Pharma Companies Chase Profits From Opioid Epidemic

The pharmaceutical industry has taken to treating secondary symptoms of opioid abuse with more pills. Meanwhile, even as the U.S. tries to regulate the trade of chemicals used to make fentanyl, a new, extremely potent drug is hitting the streets.

The Washington Post: The Drug Industry’s Answer To Opioid Addiction: More Pills

Cancer patients taking high doses of opioid painkillers are often afflicted by a new discomfort: constipation. Researcher Jonathan Moss thought he could help, but no drug company was interested in his ideas for relieving suffering among the dying. So Moss and his colleagues pieced together small grants and, in 1997, received permission to test their treatment. But not on cancer patients. Federal regulators urged them to use a less frail — and by then, rapidly expanding — group: addicts caught in the throes of a nationwide opioid epidemic. Suddenly, Moss said, investors were knocking at his door. (Cha, 10/16)

The Wall Street Journal: U.S. Seeks Curb On Chemicals Used To Make Fentanyl, A Powerful Opioid

The U.S. has asked the United Nations to help curb the trade of chemicals used to make illicit batches of fentanyl, a powerful opioid painkiller causing thousands of overdose deaths nationwide. In a letter to the U.N. Secretary-General last week, Secretary of State John Kerry asked that two fentanyl ingredients be added to a list of controlled substances in a U.N. convention that regulates narcotics internationally, according to a copy of the letter provided by the State Department. (Whalen, 10/14)

Boston Globe: Carfentanil, The Newest Killer In Opioid Epidemic, Is 10,000 Times Stronger Than Morphine 

An extremely powerful drug used as an elephant tranquilizer has quickly become a new killer in the nation’s opioid epidemic, and New England authorities and health workers are bracing for its arrival. The drug, carfentanil, is a synthetic opioid that is 10,000 times stronger than morphine and 100 times more potent than fentanyl, another deadly synthetic opioid. The emergence of a new, even more powerful drug would present a fresh challenge to local officials already battling a raging crisis. (MacQuarrie, 10/16)

And Donald Trump releases more details on his plan to battle the crisis —

Stat: Donald Trump Pledges To Increase Treatment Options For Opioid Addiction

Donald Trump delved into new details of his plan to deal with nation’s worsening opioid epidemic on Saturday, going beyond his earlier promise to “build a wall” by pledging to crack down on prescription drug abuse while offering help to those struggling with addiction. In a statement released before a rally in New Hampshire, Trump praised Congress’s passage of the Comprehensive Addiction and Recovery Act as “an important step.” He promised to increase first responders’ access to life-saving Narcan, encourage in-patient treatment for people struggling with addiction, and incentivize state and local governments to mandate treatment. (Garden 10/15)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Thursday, July 16
  • Wednesday, July 15
  • Tuesday, July 14
  • Monday, July 13
  • Friday, July 10
  • Thursday, July 9
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF